(Q40298440)

English

Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations

scientific article published on 14 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations (English)

1 reference

Europe PubMed Central

19 September 2017

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

object named as

Johan Ursing

2

0 references

object named as

Peter Aaby

6

0 references

Amabélia Rodrigues

4

object named as

Amabelia Rodrigues

1 reference

Europe PubMed Central

19 September 2017

author name string

Poul-Erik Kofoed

1

1 reference

Europe PubMed Central

19 September 2017

Anja Poulsen

3

1 reference

Europe PubMed Central

19 September 2017

Yngve Bergquist

5

1 reference

Europe PubMed Central

19 September 2017

Lars Rombo

7

1 reference

Europe PubMed Central

19 September 2017

publication date

14 August 2006

1 reference

Europe PubMed Central

19 September 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

19 September 2017

101

1 reference

Europe PubMed Central

19 September 2017

3

1 reference

Europe PubMed Central

19 September 2017

231-238

1 reference

Europe PubMed Central

19 September 2017

Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Artesunate combinations for treatment of malaria: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Should chloroquine be laid to rest?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

What is meant by intention to treat analysis? Survey of published randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Treatment of uncomplicated malaria in children in Guinea-Bissau with chloroquine, quinine, and sulfadoxine-pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Treatment of children with Plasmodium falciparum malaria with chloroquine in Guinea-Bissau.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

No benefits from combining chloroquine with artesunate for three days for treatment of Plasmodium falciparum in Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Systematic review of amodiaquine treatment in uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Parasitologic and clinical efficacy of 25 and 50 mg/kg of chloroquine for treatment of Plasmodium falciparum malaria in Rwandan children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Antimalarial Drug Toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Antimalarial drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Identifiers

10.1016/J.TRSTMH.2006.05.008

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40298440&oldid=1894189596"